---
title: Phialogics
date: 2023-04-19T06:30:05Z
modified: 2026-08-12T07:02:14Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/phialogics/"
type: portfolio
status: publish
excerpt: ""
wpid: 106620
language:
  - English
post_translations:
  - pll_643ea0fab7807
branchen22:
  - Immunology
  - Metabolic Diseases
sectors:
  - Pharmaceuticals
focus_areas:
  - Immunology
timestamp: 2026-08-12T07:02:14Z
tags:
  - English
  - pll_643ea0fab7807
  - Immunology
  - Metabolic Diseases
  - Pharmaceuticals
---

## Beschreibungstext

Phialogics is an innovative start-up in the field of autoimmune diseases. Founded in 2021 by a team of widely recognized experts in protein engineering and immunology, the company based in Basel (CH) and Heidelberg (GER) is committed to making a decisive contribution to the autoimmune disease space. The founding team is backed by strong Scientific Advisory and Supervisory Boards, which puts the company in a good position to move fast on the lead candidate and develop novel biologics.

## Unternehmenswebsite

https://www.phialogics.net

## Adresse

Phialogics AG 
c/o Switzerland Innovation Park Basel Area AG
Hegenheimermattweg 167A 
4123 Allschwil 
Switzerland

## Kontakt

Array

Array

Array

Array